These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26221937)

  • 41. Dendritic systems in drug delivery applications.
    Jain NK; Asthana A
    Expert Opin Drug Deliv; 2007 Sep; 4(5):495-512. PubMed ID: 17880273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multifunctional dendritic drug delivery systems: design, synthesis, controlled and triggered release.
    Paleos CM; Tsiourvas D; Sideratou Z; Tziveleka L
    Curr Top Med Chem; 2008; 8(14):1204-24. PubMed ID: 18855706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of oral therapeutics delivered by dendrimer-based carriers.
    Yellepeddi VK; Ghandehari H
    Expert Opin Drug Deliv; 2019 Oct; 16(10):1051-1061. PubMed ID: 31414922
    [No Abstract]   [Full Text] [Related]  

  • 44. An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy.
    Panahi Y; Mohammadhosseini M; Abadi AJ; Akbarzadeh A; Mellatyar H
    Drug Res (Stuttg); 2016 Nov; 66(11):580-586. PubMed ID: 27701713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A family of hierarchically self-assembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery.
    Wood KC; Little SR; Langer R; Hammond PT
    Angew Chem Int Ed Engl; 2005 Oct; 44(41):6704-8. PubMed ID: 16173106
    [No Abstract]   [Full Text] [Related]  

  • 46. Fabrication of zwitterionic and pH-responsive polyacetal dendrimers for anticancer drug delivery.
    Wang Y; Huang D; Wang X; Yang F; Shen H; Wu D
    Biomater Sci; 2019 Aug; 7(8):3238-3248. PubMed ID: 31165798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dendrimers for Therapeutic Delivery: Compositions, Characterizations, and Current Status.
    Nagpal K; Kumar P; Mohan A; Thakur S
    Crit Rev Ther Drug Carrier Syst; 2019; 36(4):277-304. PubMed ID: 31679189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases.
    Mintzer MA; Dane EL; O'Toole GA; Grinstaff MW
    Mol Pharm; 2012 Mar; 9(3):342-54. PubMed ID: 22126461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Research Status of Dendrimer Micelles in Tumor Therapy for Drug Delivery.
    Wang X; Zhang M; Li Y; Cong H; Yu B; Shen Y
    Small; 2023 Dec; 19(50):e2304006. PubMed ID: 37635114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymer- and liposome-based nanoparticles in targeted drug delivery.
    Venkatraman SS; Ma LL; Natarajan JV; Chattopadhyay S
    Front Biosci (Schol Ed); 2010 Jun; 2(3):801-14. PubMed ID: 20515826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
    Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
    Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-Assembling Supramolecular Dendrimers for Biomedical Applications: Lessons Learned from Poly(amidoamine) Dendrimers.
    Lyu Z; Ding L; Tintaru A; Peng L
    Acc Chem Res; 2020 Dec; 53(12):2936-2949. PubMed ID: 33275845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery.
    Hu J; Su Y; Zhang H; Xu T; Cheng Y
    Biomaterials; 2011 Dec; 32(36):9950-9. PubMed ID: 21944725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smart triblock dendritic unimolecular micelles as pioneering nanomaterials: Advancement pertaining to architecture and biomedical applications.
    Tambe P; Kumar P; Paknikar KM; Gajbhiye V
    J Control Release; 2019 Apr; 299():64-89. PubMed ID: 30797002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability.
    Jain NK; Gupta U
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1035-52. PubMed ID: 18680439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dendrimer-Enabled Therapeutic Antisense Delivery Systems as Innovation in Medicine.
    Mignani S; Shi X; Zablocka M; Majoral JP
    Bioconjug Chem; 2019 Jul; 30(7):1938-1950. PubMed ID: 31246431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dendrimers: novel polymeric nanoarchitectures for solubility enhancement.
    Gupta U; Agashe HB; Asthana A; Jain NK
    Biomacromolecules; 2006 Mar; 7(3):649-58. PubMed ID: 16529394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent Advances in Dendrimer Research for Cardiovascular Diseases.
    Yu M; Jie X; Xu L; Chen C; Shen W; Cao Y; Lian G; Qi R
    Biomacromolecules; 2015 Sep; 16(9):2588-98. PubMed ID: 26310544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptide-Decorated Dendrimers and Their Bioapplications.
    Wan J; Alewood PF
    Angew Chem Int Ed Engl; 2016 Apr; 55(17):5124-34. PubMed ID: 26990715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor extracellular acidity activated "off-on" release of bortezomib from a biocompatible dendrimer.
    Wang M; Wang Y; Hu K; Shao N; Cheng Y
    Biomater Sci; 2015 Mar; 3(3):480-9. PubMed ID: 26222291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.